title: Sarcoid-like granulomatous disease following etanercept treatment for RA.
authors.forename: Alex
authors.initials: A
authors.lastname: Kudrin
authors.forename: Edwin R
authors.initials: ER
authors.lastname: Chilvers
authors.forename: Amel
authors.initials: A
authors.lastname: Ginawi
authors.forename: Brian L
authors.initials: BL
authors.lastname: Hazleman
authors.forename: Meryl H
authors.initials: MH
authors.lastname: Griffiths
authors.forename: Sathia
authors.initials: S
authors.lastname: Thiru
authors.forename: Andrew J K
authors.initials: AJ
authors.lastname: Ostor
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001980:Bronchi / Q000473:pathology; D000068800:Etanercept; D005260:Female; D006099:Granuloma / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008206:Lymphatic Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging / Q000473:pathology; D008875:Middle Aged; D010306:Parotid Gland / Q000473:pathology*; D011859:Radiography; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D012507:Sarcoidosis / Q000139:chemically induced / Q000473:pathology
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept